PRTA Jan 2026 17.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 01:38PM EDT
| Previous close | 4.7000 |
| Open | 4.8700 |
| Bid | 4.0000 |
| Ask | 6.3000 |
| Strike | 17.50 |
| Expiry date | 2026-01-16 |
| Day's range | 4.7000 - 4.8700 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
ZacksWhy Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
Prothena (PRTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksProthena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
Prothena (PRTA) announces that Bristol Myers is exercising its option for the second time, thereby in-licensing exclusive global rights for PRX019 to potentially treat neurodegenerative diseases.
Business WireProthena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration
DUBLIN, May 28, 2024--Prothena today announced that Bristol Myers Squibb obtained the exclusive global license for PRX019 and will pay Prothena $80 million.
© 2024 Yahoo. All rights reserved.